• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assay Kits
      • Transcreener® ADP² Kinase Assay Kits
        • Transcreener® ADP2 Assay Kit – FP Readout
        • Transcreener® ADP2 Assay Kit – FI Readout
        • Transcreener® ADP2 Assay Kit – TR-FRET Readout
      • Transcreener® ADO CD73 Assay Kit
      • Transcreener® ADPR Assay Kit
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay Kits
        • Transcreener® AMP2/GMP2 FP Assay
        • Transcreener® AMP2/GMP2 Assay Kit – TR-FRET Readout
      • Transcreener® cGAMP cGAS Assay Kits
        • Transcreener® cGAMP Assay Kit – FP Readout
        • Transcreener® cGAMP Assay Kit – TR-FRET Readout
      • Transcreener dAMP Exonuclease Assay Kit
      • Transcreener® EPIGEN SAH Methyltransferase Assay Kit
      • Transcreener® GDP GTPase Assay Kits
        • Transcreener® GDP Assay Kit – FP Readout
        • Transcreener® GDP Assay Kit – FI Readout
        • Transcreener® GDP Assay Kit – TR-FRET Readout
      • Transcreener® UDP² Glycosyltransferase Assay Kits
        • Transcreener® UDP2 Assay Kit – FP Readout
        • Transcreener® UDP2 Assay Kit – FI Readout
        • Transcreener® UDP2 Assay Kit – TR-FRET Readout
      • Transcreener® 2-5A OAS Assay Kit
    • AptaFluor® HTS Assay Kits
      • AptaFluor® SAH Methyltransferase Assay Kit
    • Enzyme Assay Systems
      • CD38 Assay System
      • PARG Assay System
      • TREX1 Assay System
      • WRN Helicase Assay System
    • Recombinant Enzymes
      • Human CD38 Enzyme
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
      • Human PARG Enzyme
      • Human TREX1 Enzyme
      • Human WRN Helicase Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • GTPase Profiling Services
    • ATPase Profiling Services
  • Assays by Target
    • Kinase Assays
      • ADK Assays – Application
      • AMPK Assays – Application
      • IKK-beta Assays – Application
      • IRAK4 Assays – Application
      • JAK1 Assays – Application
      • JAK3 Assays – Application
      • MAPK8 Assays – Application
      • PKR Assays – Application
      • RIPK1 Assays – Application
      • RIPK2 Assays – Application
      • TBK1 Assays – Application
    • GTPase Assays
      • GAP Assays – Application
      • GEF Assays – Application
      • KRAS Assays – Application
      • HRAS Assays – Application
      • NRAS Assays – Application
      • RRAS Assays – Application
      • Rac1 Assays – Application
      • RhoA Assays – Application
      • RhoC Assays – Application
      • Cdc42 Assays – Application
      • Ran Assays – Application
    • Methyltransferase Assays
      • EZH2 Assays – Application
      • G9a Assays – Application
      • METTL3/METTL14 Assays – Application
      • SET7/9 Assays – Application
      • SET8 Assays – Application
      • PRMT1 Assays – Application
      • PRMT3 Assays – Application
      • PRMT4 Assays – Application
      • PRMT5 Assays – Application
    • STING Pathway Assays
      • cGAS Assay Kits
      • ENPP1 Assays – Application
      • TREX1 Assay System
      • IKK-beta Assays – Application
      • TBK1 Assays – Application
    • Nucleotidase Assays
      • CD38 Assay System
      • CD39 Assays – Application
      • CD73 Activity Assay Kits
      • PARG Assay System
    • Helicase / ATPase Assays
      • DDX3 Assays – Application
      • NSP13 Assays – Application
      • p97 Assays – Application
      • Ketohexokinase Assays – Application
      • WRN Helicase Assay System
    • Glycosyltransferase Assays
      • Toxin B Assays – Application
      • GALNT2 Assays – Application
      • GALNT3 Assays – Application
      • BGalT1 Assays – Application
    • Phosphodiesterase Assays
      • PDE3 Assays – Application
      • PDE4 Assays – Application
      • PDE5 Assays – Application
      • PDE7 Assays – Application
    • Ligase and Synthetase Assays
      • SUMO E1 Assays – Application
      • Acetyl CoA Synthetase Assays – Application
    • Exonuclease Assays
      • TREX1 Assay System
      • WRN Exonuclease Assays – Application
    • OAS Assays
      • OAS1 Assay Kits
    • Other Enzyme Assays
      • NUDT5 Assays – Application
  • Resources
    • Technical Manuals
    • Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
      • DNA Damage Response and Innate Immunity
    • Technical Support
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

MAPK1, An Elusive Regulator of Innate Immunity

by Bellbrook Labs / Wednesday, 23 February 2022 / Published in HTS Assays, Innate Immunity
Researcher working on MAPK1 pathway

Mitogen-Activated Protein Kinases (MAPKs) and MAPK Signaling Cascade

Mitogen-activated protein kinases (MAPKs) are Ser/Thr kinases involved in converting extracellular signals to a large spectrum of fundamental cellular processes such as apoptosis, cell division, metabolism survival, etc. This signaling cascade is known as the MAPK pathway. MAPKs are highly conserved among eukaryotes, which mirrors its indispensable function in maintaining cellular physiology. A total of 14 MAPKs have been characterized in mammals, and these MAPKs can be categorized into two forms – conventional and atypical1. Conventional MAPKs include Extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun amino (N)-terminal kinases 1/2/3 (JNK1/2/3), p38 isoforms, and ERK5, while atypical MAPKs, which are less studied, include ERK3/4, ERK7, and Nemo-like kinase (NLK). All MAPKs contain the Ser/Thr kinase domain, which is needed to catalyze the phosphorylation of serine and threonine residues, therefore activating downstream effectors of the MAPK signaling pathway.

MAPK1 Acts in the ERK1/2 Signaling Module

MAPK1, commonly referred to as ERK2, is a conventional MAPK. Known as the ‘classical’ MAPK, ERK2 is involved with ERK1 (MAPK3) in the ERK1/2 signaling module. ERK1 and ERK2 are highly similar, sharing 83% amino acid identity1. A plethora of upstream signals such as growth factors, inflammatory cytokines, cellular stress, and mitogens can activate ERK1/2. In turn, activated ERK1/2 phosphorylates and activates key transcription factors such as c-Myc, c-Fos, Elk1, and Ets, which serve to initiate the production of response proteins. At present, there are about 200 known substrates of ERK1/22, which partake in various cellular processes to respond to upstream signals appropriately.

Involvement of MAPK1 in Innate Immunity

Because the ERK1/2 signaling module was found to be a critical regulator of cell cycle and proliferation, its role in cancer has been extensively studied3. However, MAPK signaling is also discovered to play pivotal roles in regulating innate immunity. Innate immunity serves as the first line of defense in the presence of pathogenic infections where the pattern recognition receptors (PPRs) recognize pathogen-associated molecular patterns (PAMPs) and induce inflammatory responses such as the release of chemokines and cytokines via immune signaling pathways such as the MAPK pathway4.

One group of PPRs known as Toll-like receptors (TLRs) activates the MAPK signaling cascade in the presence of PAMPs to induce the production of cytokines such as Tumor necrosis factor-α (TNFa), interleukin-1 (IL-1), IL-6, and IL-125. ERK is especially important in regulating TNFa production at a transcriptional and post-transcriptional level. A group of researchers showed that mice deficient in TPL2, a MAPK kinase that acts upstream of ERK1/2, cannot produce TNF-α in the presence of an inflammatory stimuli6. Therefore, MAPKs, including ERK, are critical for TNF-α post-transcriptional regulation. Transcriptionally, ERK is involved in inducing TNF-α gene expression by activating transcriptional factor AP-1 and/or activating protein kinases MSK1/2 which in turn activates CREB and transcription ATF-1, components important for TNF-α production7.

More insights have been shed in recent years, demystifying the role of MAPKs such as MAPK1 in innate immunity. However, current knowledge is still relatively limited. More studies would have to be done to further elucidate the relationship between ERK, TLRs, and cytokine production, especially in a cell-specific manner.

Learn how Transcreener Kinase Assays can help accelerate your discovery.

References

  1. Cargnello, M. & Roux, P. P. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases. Microbiol Mol Biol Rev 75, 50–83 (2011). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063353/
  2. Wortzel, I. & Seger, R. The ERK Cascade. Genes Cancer 2, 195–209 (2011). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128630/
  3. Guo, Y.-J. et al. ERK/MAPK signalling pathway and tumorigenesis (Review). Experimental and Therapeutic Medicine 19, 1997–2007 (2020). https://pubmed.ncbi.nlm.nih.gov/32104259/
  4. Arthur, J. S. C. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13, 679–692 (2013). https://www.nature.com/articles/nri3495
  5. Dong, C., Davis, R. J. & Flavell, R. A. MAP kinases in the immune response. Annu Rev Immunol 20, 55–72 (2002). https://pubmed.ncbi.nlm.nih.gov/11861597/
  6. Rousseau, S. et al. TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages. Journal of Cell Science 121, 149–154 (2008). https://journals.biologists.com/jcs/article/121/2/149/35225/TPL2-mediated-activation-of-ERK1-and-ERK2
  7. Sabio, G. & Davis, R. J. TNF and MAP kinase signaling pathways. Semin Immunol 26, 237–245 (2014). https://pubmed.ncbi.nlm.nih.gov/24647229/
Tagged under: Lead Discovery Services, MAPK1, Transcreener ADP Kinase Assay

What you can read next

Scientist using Transcreener Assay to Study PIK3CA Mutation
Transcreener ADP2 Assay Helps Uncover the Mechanics of Oncogenic PIK3CA Mutations
Performing a Kinase Assay Kit in a Lab
A Kinase Assay Kit to Interrogate Innate Immunity Targets
Info book on cancer and RAFK1's relation
RAF1 & Immunity: A Future Model For Cancer Research?

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • METTL3 Acts as a Tumor Promoter

    METTL3 is a Significant Focus in Cancer Research

    Methyltransferase-like 3 (METTL3) is a 70 kDa p...
  • RNA Methyltransferase METTL16 Performing Many Functions

    METTL16: An RNA Methyltransferase That Wears Many Hats

    Methyltransferase-like protein 16 (METTL16) is ...
  • Researchers Identify PDE5 Inhibitor Using Transcreener Assay

    Researchers Use Transcreener Assay to Identify New PDE5 Inhibitor

    Phosphodiesterase 5 (PDE5) is most familiar in ...
  • DDX6 regulates RNA transcription and translation

    DDX6 Regulates mRNA Transcription & Translation Pathways

    DDX6 (RCK/p54) was first isolated from the RC-K...
  • Scientist using Transcreener Assay to Study PIK3CA Mutation

    Transcreener ADP2 Assay Helps Uncover the Mechanics of Oncogenic PIK3CA Mutations

    The PIK3CA gene codes for the 110 kDa catalytic...

Archives

BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2023 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP